A total of 560 ovarian cancer tumors from two cohorts (Hennessy et al. [16], and The Cancer Genome Atlas Network– Ovarian [18]) were included, 20.5% of which were known to be BRCA1/2-deficient (N = 115/560; Table 1). The gene discussed is BRCA1; the disease is ovarian cancer.